Elham Barazeghi
Researcher at Department of Surgical Sciences; Endocrine Surgery
- E-mail:
- elham.barazeghi@uu.se
- Visiting address:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA - Postal address:
- Akademiska sjukhuset, ingång 70, 1 tr
751 85 UPPSALA
More information is available to staff who log in.
Publications
Selection of publications
- PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors (2019)
- Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors. (2018)
- A role for TET2 in parathyroid carcinoma (2017)
- 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma (2016)
- The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors (2014)
Recent publications
- EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine (2021)
- PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors (2019)
- Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors. (2018)
- A role for TET2 in parathyroid carcinoma (2017)
- 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma (2016)
All publications
Articles
- EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine (2021)
- PTPRM, a candidate tumor suppressor gene in small intestinal neuroendocrine tumors (2019)
- Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors. (2018)
- A role for TET2 in parathyroid carcinoma (2017)
- 5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma (2016)
- The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors (2014)
